Header Logo

Jeffrey Borgia

Concepts (322)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
29
2024
507
8.210
Why?
Carcinoma, Non-Small-Cell Lung
21
2024
218
7.270
Why?
Biomarkers, Tumor
12
2024
179
4.290
Why?
Autoantibodies
5
2021
71
1.960
Why?
Multiple Pulmonary Nodules
3
2022
11
1.850
Why?
Insulin-Like Growth Factor I
6
2024
52
1.440
Why?
Biomarkers
9
2024
556
1.300
Why?
Neoplasm Recurrence, Local
4
2017
186
1.160
Why?
Immunoassay
3
2018
37
1.120
Why?
Insulin-Like Growth Factor Binding Proteins
3
2015
9
0.990
Why?
Body Composition
2
2024
62
0.960
Why?
Solitary Pulmonary Nodule
2
2015
13
0.920
Why?
Prognosis
10
2024
758
0.920
Why?
Adenocarcinoma
5
2018
123
0.910
Why?
Drug Resistance, Neoplasm
3
2020
62
0.900
Why?
Humans
48
2024
26286
0.900
Why?
Neoplasm Staging
7
2024
314
0.830
Why?
Middle Aged
21
2024
8601
0.820
Why?
Immunotherapy
2
2024
48
0.780
Why?
Early Detection of Cancer
5
2022
85
0.780
Why?
Aged
21
2024
8765
0.760
Why?
Cachexia
2
2019
13
0.730
Why?
Antineoplastic Agents, Immunological
1
2021
15
0.730
Why?
Lymphoma, Non-Hodgkin
2
2019
37
0.720
Why?
Aged, 80 and over
13
2024
4675
0.720
Why?
Female
25
2024
14539
0.690
Why?
Male
24
2024
14162
0.680
Why?
HLA Antigens
2
2021
15
0.660
Why?
Erlotinib Hydrochloride
2
2020
10
0.650
Why?
Algorithms
7
2022
366
0.650
Why?
Histocompatibility Antigens Class II
1
2018
6
0.610
Why?
Syndecan-1
1
2018
4
0.610
Why?
Histocompatibility Antigens Class I
1
2018
17
0.610
Why?
Vimentin
2
2016
2
0.600
Why?
Neovascularization, Pathologic
2
2015
33
0.600
Why?
Nerve Growth Factors
1
2018
35
0.590
Why?
Inflammation Mediators
1
2018
58
0.580
Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
34
0.550
Why?
Tandem Mass Spectrometry
2
2013
21
0.540
Why?
Lymphatic Metastasis
3
2012
80
0.530
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2017
224
0.530
Why?
Kidney Transplantation
2
2016
120
0.530
Why?
Cytokines
2
2014
226
0.480
Why?
Graft Rejection
2
2016
63
0.480
Why?
Insulin-Like Growth Factor II
1
2014
8
0.480
Why?
Adult
12
2018
7448
0.480
Why?
Predictive Value of Tests
5
2014
460
0.470
Why?
Cohort Studies
7
2024
1838
0.450
Why?
Doxazosin
1
2013
1
0.450
Why?
Adrenergic alpha-1 Receptor Antagonists
1
2013
1
0.450
Why?
Chloroquine
1
2013
7
0.450
Why?
Melanins
1
2013
7
0.450
Why?
Immunoglobulin G
3
2022
87
0.440
Why?
Sulfonamides
1
2013
42
0.440
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
9
0.430
Why?
Multivariate Analysis
4
2017
305
0.420
Why?
Immunoglobulin M
2
2022
14
0.410
Why?
C-Peptide
1
2011
6
0.390
Why?
Sensitivity and Specificity
3
2022
485
0.390
Why?
Retrospective Studies
7
2019
3367
0.380
Why?
Cell Line, Tumor
7
2020
234
0.380
Why?
Blood Chemical Analysis
1
2010
13
0.360
Why?
Survival Analysis
3
2021
235
0.360
Why?
Hematologic Tests
1
2010
6
0.360
Why?
Protein Array Analysis
1
2010
10
0.360
Why?
Protein Kinase Inhibitors
3
2020
45
0.350
Why?
ErbB Receptors
4
2020
51
0.340
Why?
Area Under Curve
4
2014
57
0.330
Why?
Lymph Nodes
1
2009
62
0.310
Why?
Disease-Free Survival
3
2017
159
0.310
Why?
Treatment Outcome
6
2024
3391
0.300
Why?
Risk Assessment
4
2017
629
0.290
Why?
Body Weight
3
2024
121
0.290
Why?
Antigens, Neoplasm
2
2021
38
0.270
Why?
Diagnosis, Differential
2
2018
347
0.250
Why?
Gene Expression Profiling
2
2024
125
0.250
Why?
Antibodies, Viral
2
2022
53
0.250
Why?
Animals
11
2020
3538
0.250
Why?
Proteomics
2
2018
90
0.230
Why?
Young Adult
4
2018
1886
0.220
Why?
ROC Curve
2
2014
137
0.220
Why?
Chondrocytes
3
2014
148
0.220
Why?
Pneumonectomy
2
2017
67
0.220
Why?
Reproducibility of Results
3
2014
679
0.220
Why?
Prospective Studies
3
2024
1668
0.210
Why?
Survival Rate
2
2018
322
0.210
Why?
Mutation
3
2020
315
0.210
Why?
Diabetes Mellitus, Type 2
2
2016
171
0.210
Why?
Vaccines
1
2022
7
0.210
Why?
Gene Expression Regulation, Neoplastic
3
2024
95
0.210
Why?
Immunoglobulin E
1
2022
11
0.210
Why?
Immunoglobulin A
1
2022
14
0.210
Why?
Complement C1q
1
2022
7
0.200
Why?
Seroconversion
1
2022
1
0.200
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2022
5
0.200
Why?
Sarcopenia
2
2019
31
0.200
Why?
Body Mass Index
1
2024
427
0.200
Why?
Spike Glycoprotein, Coronavirus
1
2022
17
0.200
Why?
Organoids
1
2021
8
0.190
Why?
Precision Medicine
1
2021
25
0.190
Why?
Follow-Up Studies
2
2018
1738
0.190
Why?
Neoplasms
2
2021
222
0.190
Why?
Neoplasm Invasiveness
3
2017
77
0.190
Why?
Colorectal Neoplasms
1
2022
78
0.190
Why?
Pilot Projects
1
2022
378
0.190
Why?
Bone Morphogenetic Protein 7
2
2011
33
0.190
Why?
B7-H1 Antigen
1
2021
9
0.190
Why?
Proportional Hazards Models
3
2017
326
0.190
Why?
Programmed Cell Death 1 Receptor
1
2021
14
0.180
Why?
Observer Variation
1
2021
93
0.180
Why?
Tomography, X-Ray Computed
2
2015
723
0.180
Why?
Endothelin-1
1
2020
7
0.180
Why?
Mass Screening
1
2022
166
0.180
Why?
Biochemistry
1
2000
1
0.180
Why?
Disease Progression
2
2014
687
0.180
Why?
Proteins
1
2000
54
0.170
Why?
Cardiovascular Diseases
1
2024
333
0.170
Why?
Weight Loss
2
2019
120
0.170
Why?
Receptors, CXCR
1
2019
1
0.170
Why?
Epithelial-Mesenchymal Transition
2
2019
5
0.170
Why?
Esophagectomy
1
2019
21
0.170
Why?
Patient Selection
1
2021
194
0.170
Why?
Protein Binding
3
2014
113
0.170
Why?
Esophageal Neoplasms
1
2019
44
0.160
Why?
RNA, Small Untranslated
1
2018
1
0.160
Why?
Channelopathies
1
2018
5
0.160
Why?
CA1 Region, Hippocampal
1
2018
8
0.160
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2018
10
0.160
Why?
Cell Movement
2
2016
77
0.150
Why?
Carcinoma, Large Cell
1
2018
12
0.150
Why?
Neuronal Plasticity
1
2018
39
0.150
Why?
Pyramidal Cells
1
2018
29
0.150
Why?
Transcriptome
3
2024
81
0.150
Why?
SOS1 Protein
1
2016
4
0.140
Why?
Proto-Oncogene Proteins c-cbl
1
2016
12
0.140
Why?
rac1 GTP-Binding Protein
1
2016
12
0.140
Why?
Kidney Tubules
1
2016
7
0.140
Why?
Carcinoma, Squamous Cell
1
2018
160
0.140
Why?
Adaptor Proteins, Signal Transducing
1
2016
61
0.130
Why?
Adaptor Proteins, Vesicular Transport
1
2016
42
0.130
Why?
Muscle, Skeletal
1
2019
361
0.130
Why?
Cattle
2
2013
135
0.130
Why?
Metformin
1
2016
18
0.130
Why?
Hypoglycemic Agents
1
2016
33
0.130
Why?
Computational Biology
2
2014
21
0.130
Why?
Aggrecans
2
2013
52
0.130
Why?
Cognition
1
2024
1291
0.130
Why?
Mice, Transgenic
4
2019
201
0.130
Why?
Protein-Arginine N-Methyltransferases
1
2015
2
0.130
Why?
Risk Factors
3
2024
2265
0.120
Why?
Repressor Proteins
1
2015
25
0.120
Why?
Oligonucleotide Array Sequence Analysis
2
2011
49
0.120
Why?
Collagen Type X
1
2014
2
0.120
Why?
Mice
5
2020
1290
0.120
Why?
Leukemia, Myeloid, Acute
1
2015
49
0.120
Why?
Minnesota
1
2014
7
0.120
Why?
Hematologic Neoplasms
1
2014
17
0.120
Why?
Kidney Failure, Chronic
1
2016
151
0.120
Why?
Microspheres
1
2014
23
0.110
Why?
Cell Differentiation
1
2014
124
0.110
Why?
Metabolic Syndrome
1
2014
55
0.110
Why?
Choroid
1
2013
1
0.110
Why?
Retinal Pigment Epithelium
1
2013
1
0.110
Why?
Iris
1
2013
2
0.110
Why?
Biological Assay
1
2013
6
0.110
Why?
Illinois
1
2014
231
0.110
Why?
Reference Values
1
2014
184
0.110
Why?
src-Family Kinases
1
2013
7
0.110
Why?
Collagen Type IV
2
2004
4
0.110
Why?
Gene Expression Regulation
2
2014
237
0.110
Why?
Feasibility Studies
1
2014
210
0.110
Why?
In Vitro Techniques
1
2013
171
0.110
Why?
Cell Proliferation
3
2021
162
0.110
Why?
Postoperative Complications
1
2019
869
0.110
Why?
Chondroitin Sulfates
1
2013
5
0.110
Why?
Chemokine CCL3
1
2013
8
0.110
Why?
Granuloma
1
2013
13
0.110
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
13
0.110
Why?
Amino Acid Sequence
5
2015
133
0.110
Why?
Chemokine CXCL12
1
2013
9
0.110
Why?
Respiratory Tract Infections
1
2013
22
0.110
Why?
Interleukin-10
1
2013
17
0.110
Why?
Molecular Sequence Data
5
2015
163
0.110
Why?
Interleukin-1beta
1
2013
53
0.110
Why?
Interleukin-6
1
2013
72
0.100
Why?
Decision Support Techniques
1
2012
48
0.100
Why?
Chronic Disease
1
2014
419
0.100
Why?
Pneumonia
1
2013
70
0.100
Why?
Vascular Endothelial Growth Factor A
2
2024
66
0.100
Why?
Tumor Necrosis Factor-alpha
1
2013
186
0.100
Why?
Obesity
1
2014
279
0.100
Why?
Animal Experimentation
1
2010
3
0.090
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
10
0.090
Why?
Radiography
1
2013
616
0.090
Why?
Serum
1
2010
7
0.090
Why?
Antibodies, Neoplasm
1
2010
13
0.090
Why?
Kaplan-Meier Estimate
3
2017
162
0.090
Why?
Intervertebral Disc
1
2010
127
0.080
Why?
Case-Control Studies
1
2010
566
0.080
Why?
Mass Spectrometry
3
2014
37
0.080
Why?
Sodium Dodecyl Sulfate
1
2008
3
0.080
Why?
Electrophoresis, Polyacrylamide Gel
1
2008
24
0.080
Why?
Phosphoproteins
1
2008
25
0.080
Why?
Preoperative Care
1
2009
122
0.080
Why?
Alzheimer Disease
2
2018
2062
0.080
Why?
Xenograft Model Antitumor Assays
2
2020
21
0.080
Why?
Metals
1
2008
142
0.070
Why?
Signal Transduction
3
2014
409
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
119
0.070
Why?
Cartilage, Articular
1
2011
413
0.070
Why?
Melanoma
2
2004
48
0.060
Why?
Hyaluronan Receptors
1
2004
5
0.060
Why?
Metalloproteases
1
2004
7
0.060
Why?
Peptide Fragments
2
2004
74
0.060
Why?
Brain-Derived Neurotrophic Factor
1
2024
43
0.060
Why?
Real-Time Polymerase Chain Reaction
2
2015
33
0.050
Why?
Adolescent
1
2009
2080
0.050
Why?
Glycosylation
1
2022
15
0.050
Why?
Antibody Formation
1
2022
18
0.050
Why?
Proline
1
2002
10
0.050
Why?
Microsatellite Instability
1
2022
8
0.050
Why?
Tumor Microenvironment
1
2022
17
0.050
Why?
Disease Models, Animal
2
2018
574
0.050
Why?
Drug Screening Assays, Antitumor
1
2021
10
0.050
Why?
Fluorescence
1
2021
11
0.050
Why?
Loss of Heterozygosity
1
2021
5
0.050
Why?
Genomics
1
2021
53
0.050
Why?
Cross-Sectional Studies
1
2024
853
0.050
Why?
Biological Availability
1
2020
19
0.050
Why?
Vasoconstriction
1
2020
15
0.050
Why?
Base Sequence
2
2014
89
0.040
Why?
Tumor Cells, Cultured
2
2015
116
0.040
Why?
RNA, Messenger
2
2015
264
0.040
Why?
beta-Arrestins
1
2019
1
0.040
Why?
Neoplasms, Experimental
1
2019
7
0.040
Why?
Neuropsychological Tests
1
2024
1223
0.040
Why?
Models, Biological
1
2021
306
0.040
Why?
MAP Kinase Signaling System
1
2019
35
0.040
Why?
Antineoplastic Agents
1
2020
177
0.040
Why?
Endoplasmic Reticulum
1
2018
18
0.040
Why?
Sex Factors
1
2019
450
0.040
Why?
Action Potentials
1
2018
116
0.040
Why?
Leukocyte Count
1
2017
64
0.030
Why?
Time-Lapse Imaging
1
2016
5
0.030
Why?
Neoplasm Transplantation
1
2016
13
0.030
Why?
Ubiquitination
1
2016
10
0.030
Why?
A549 Cells
1
2016
10
0.030
Why?
Lymphocytes
1
2017
59
0.030
Why?
Fibrosis
1
2016
26
0.030
Why?
Neutrophils
1
2017
96
0.030
Why?
Neoplasm Metastasis
1
2016
93
0.030
Why?
Atrophy
1
2016
90
0.030
Why?
Graft Survival
1
2016
90
0.030
Why?
Biopsy
1
2016
200
0.030
Why?
Fluorescent Antibody Technique, Indirect
1
2015
5
0.030
Why?
Twist-Related Protein 1
1
2015
3
0.030
Why?
Arginine
1
2015
16
0.030
Why?
Sequence Homology, Amino Acid
1
2015
29
0.030
Why?
Cadherins
1
2015
34
0.030
Why?
RNA, Small Interfering
1
2015
69
0.030
Why?
Blotting, Western
1
2015
135
0.030
Why?
Two-Hybrid System Techniques
1
2014
2
0.030
Why?
Enhancer Elements, Genetic
1
2014
9
0.030
Why?
Diabetes Mellitus
1
2016
126
0.030
Why?
Cyclooxygenase 2
1
2014
27
0.030
Why?
Hypertrophy
1
2014
18
0.030
Why?
Binding Sites
1
2014
65
0.030
Why?
Lipid Metabolism
1
2014
27
0.030
Why?
Nuclear Proteins
1
2015
80
0.030
Why?
Cognitive Dysfunction
1
2024
1020
0.030
Why?
Genetic Association Studies
1
2014
83
0.030
Why?
Insulin Resistance
1
2014
45
0.030
Why?
Wound Healing
1
2015
149
0.030
Why?
DNA Methylation
1
2015
122
0.030
Why?
Transcription Factors
1
2014
159
0.030
Why?
Proto-Oncogene Proteins c-met
1
2013
3
0.030
Why?
Protein Kinase C beta
1
2013
7
0.030
Why?
Protein Structure, Secondary
2
2004
17
0.030
Why?
Cell Adhesion
2
2004
32
0.030
Why?
Ligands
2
2004
40
0.030
Why?
Protein Kinase C
1
2013
48
0.030
Why?
Enzyme Activation
1
2013
104
0.030
Why?
Cell Survival
1
2013
113
0.030
Why?
Phosphorylation
1
2013
139
0.030
Why?
Reference Standards
1
2013
23
0.030
Why?
Oligosaccharides
1
2013
17
0.030
Why?
Cell Membrane
1
2013
92
0.030
Why?
Support Vector Machine
1
2011
5
0.020
Why?
Least-Squares Analysis
1
2011
7
0.020
Why?
Presenilin-1
1
2010
8
0.020
Why?
Metabolism
1
2010
5
0.020
Why?
Smad Proteins
1
2010
3
0.020
Why?
Gels
1
2010
13
0.020
Why?
Nitriles
1
2010
12
0.020
Why?
Chromatography, Liquid
1
2010
22
0.020
Why?
Drug Synergism
1
2010
38
0.020
Why?
Amyloid beta-Protein Precursor
1
2010
20
0.020
Why?
Triazoles
1
2010
27
0.020
Why?
Bone Matrix
1
2010
26
0.020
Why?
Models, Animal
1
2010
109
0.020
Why?
Administration, Oral
1
2010
100
0.020
Why?
Antipsychotic Agents
1
2010
57
0.020
Why?
Proteoglycans
1
2010
130
0.020
Why?
Carrier Proteins
1
2010
81
0.020
Why?
tau Proteins
1
2010
225
0.020
Why?
Cells, Cultured
1
2010
509
0.020
Why?
Caseins
1
2008
1
0.020
Why?
Phosphopeptides
1
2008
1
0.020
Why?
Manganese
1
2008
3
0.020
Why?
Ovalbumin
1
2008
6
0.020
Why?
Aging
1
2018
1538
0.020
Why?
Aluminum
1
2008
9
0.020
Why?
Iron
1
2008
21
0.020
Why?
Serum Albumin
1
2008
21
0.020
Why?
Titanium
1
2008
172
0.020
Why?
DNA Primers
1
2004
45
0.010
Why?
Antigens, CD
1
2004
51
0.010
Why?
Stereoisomerism
1
2002
3
0.010
Why?
Drug Stability
1
2002
2
0.010
Why?
Biophysical Phenomena
1
2002
29
0.010
Why?
Basement Membrane
1
2002
11
0.010
Why?
Biophysics
1
2002
35
0.010
Why?
Borgia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (322)
Explore
_
Co-Authors (57)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_